Logotype for Corvus Pharmaceuticals Inc

Corvus Pharmaceuticals (CRVS) Proxy filing summary

Event summary combining transcript, slides, and related documents.

Logotype for Corvus Pharmaceuticals Inc

Proxy filing summary

24 Apr, 2026

Voting matters and shareholder proposals

  • Election of two Class I Directors for terms expiring at the 2029 annual meeting is proposed, with board recommendation to vote FOR.

  • Ratification of PricewaterhouseCoopers LLP as independent registered public accounting firm for fiscal year ending December 31, 2026, recommended FOR.

  • Advisory vote to approve compensation of named executive officers, with board recommendation to vote FOR.

Board of directors and corporate governance

  • Board recommends the election of two director nominees to serve until the 2029 annual meeting.

Executive compensation and say-on-pay

  • Shareholders are asked to approve, on a non-binding basis, the compensation of named executive officers.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more